4E-BP Antibodies

Santa Cruz Biotechnology features a diverse variety of 4E-BP monoclonal antibodies for studying eukaryotic translation initiation factor 4E-binding proteins. Multiple research applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). 4E-BP proteins regulate protein synthesis by binding to the translation initiation factor eIF4E, which inhibits cap-dependent translation. This regulation influences cellular processes including growth, proliferation, and stress response mechanisms. Understanding 4E-BP protein function has significant implications for cancer research and diseases linked to abnormal protein synthesis. Researchers can investigate translation regulation pathways through detailed molecular analysis. Advanced detection methods enable precise visualization and quantification of 4E-BP expression patterns. Experimental approaches using specific molecular markers help reveal regulatory networks in both normal and disease states. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by enabling researchers to uncover new insights into translation control mechanisms and their impact on human health.